Strata Critical Medical, Inc.
SRTA· Nasdaq
Filed Mar 3, 2026 · 10-K · 62 days after period end · 0001628280-26-013628
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022 |
|---|---|---|---|---|
| Revenue | $66.79M | — | $47.48M | $38.14M |
| Net Income | -$8.83M | -$9.79M | -$33.94M | -$27.26M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 3, 2026 · 62 d after period end